Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ALGS
#3397
Aligos Therapeutics, Inc. Common Stock
7.030
0
+1.30%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+1.30%
Mudança mensal
-19.10%
Mudança em 6 meses
-28.19%
Mudança anual
-28.19%
Fechamento anterior
6.940
0
Open
7.030
0
Bid
Ask
Low
7.030
0
High
7.030
0
Volume
2
Mercados
Ações
Cuidados de saúde
ALGS
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
1.53 M
1.58 M
1.59 M
2.9 M
6.11 M
—
Valuation ratios
Enterprise value
—
—
—
—
—
—
Price to earnings ratio
—
—
—
—
-1.9
-4.32
Price to sales ratio
—
—
—
—
46.99
87.35
Price to cash flow ratio
—
—
—
—
3.09
5.58
Price to book ratio
—
—
—
—
8.61
9.32
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.41
-0.55
-0.65
-0.58
-1.87
-1.5
Return on equity %
-0.49
-0.69
-0.92
-0.95
-4.53
-3.38
Return on invested capital %
-1 521.51
-1 526.49
-1 163.95
-1 725.24
-2 679.38
-3 114.08
Gross margin %
—
—
—
100
100
400
Operating margin %
—
—
—
-840.02
-1 678.67
-7 847.54
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
-835.75
-2 470.55
-11.14 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
8.26
5.25
4.03
5.9
2.86
21.43
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0.07
0.05
0.04
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
4 682.15
17.65 K
69.13 K
-30.73
-12.89
-9.49
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
-15.35 K
-31.4 K
-109.54 K
52.79
9.08
48.19
Net current asset value per share
-15.76 K
-31.19 K
-116.28 K
54.89
9.92
50.61
Tangible book value per share
-13.87 K
-28.19 K
-90.47 K
35.82
-4.62
26.97
Working capital per share
-13.85 K
-25.25 K
-87.44 K
45.59
6.45
40.55
Book value per share
-13.87 K
-28.19 K
-90.47 K
35.82
-4.62
26.97
Notícias
Aligos Therapeutics mantém recomendação de compra da H.C. Wainwright com avanço do pevifoscorvir
Aligos Therapeutics stock maintains Buy rating at H.C. Wainwright on pevifoscorvir progress
Ações da Aligos Therapeutics sobem com avanço do estudo de Fase 2 para HBV
Aligos Therapeutics stock rises on Phase 2 HBV study progress
Aligos relata progresso em estudo de medicamento para hepatite B de Fase 2
Aligos reports progress on Phase 2 hepatitis B drug study
Aligos Therapeutics nomeia James Hassard como diretor comercial
Aligos therapeutics appoints James Hassard as chief commercial officer
Ações da Aligos Therapeutics recebem classificação de Compra pela UBS
Aligos Therapeutics stock initiated with Buy rating at UBS on liver disease pipeline
Aligos relata efeito sinérgico de perda de peso com agonista THR-β
Aligos reports synergistic weight loss effect with THR-β agonist